Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial

BACKGROUND. Both human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) may increase cardiovascular disease (CVD) risk. Vascular function assessments can be used to study CVD pathogenesis. We compared the effect of immediate versus deferred ART initiation at CD4 counts >500...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Jason V., Hullsiek, Katherine Huppler, Engen, Nicole Wyman, Nelson, Ray, Chetchotisakd, Ploenchan, Gerstoft, Jan, Jessen, Heiko, Losso, Marcelo, Markowitz, Norman, Munderi, Paula, Papadopoulos, Antonios, Shuter, Jonathan, Rappoport, Claire, Pearson, Mary T., Finley, Elizabeth, Babiker, Abdel, Emery, Sean, Duprez, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144656/
https://www.ncbi.nlm.nih.gov/pubmed/27942541
http://dx.doi.org/10.1093/ofid/ofw213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144656/
https://www.ncbi.nlm.nih.gov/pubmed/27942541
http://dx.doi.org/10.1093/ofid/ofw213

Ejemplares similares